Merit Medical Systems, Inc. (MMSI): Price and Financial Metrics


Merit Medical Systems, Inc. (MMSI)

Today's Latest Price: $57.91 USD

0.10 (0.17%)

Updated Jan 25 9:40am

Add MMSI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 186 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MMSI Stock Summary

  • Merit Medical Systems Inc's stock had its IPO on February 26, 1992, making it an older stock than 81.46% of US equities in our set.
  • With a year-over-year growth in debt of -16.03%, Merit Medical Systems Inc's debt growth rate surpasses merely 17.74% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Merit Medical Systems Inc is reporting a growth rate of -168.51%; that's higher than only 11.49% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Merit Medical Systems Inc, a group of peers worth examining would be VOXX, ALOT, VG, NVT, and OPK.
  • Visit MMSI's SEC page to see the company's official filings. To visit the company's web site, go to www.merit.com.

MMSI Stock Price Chart Interactive Chart >

Price chart for MMSI

MMSI Price/Volume Stats

Current price $57.91 52-week high $58.70
Prev. close $57.81 52-week low $25.18
Day low $57.30 Volume 5,761
Day high $57.91 Avg. volume 271,595
50-day MA $54.95 Dividend yield N/A
200-day MA $46.99 Market Cap 3.22B

Merit Medical Systems, Inc. (MMSI) Company Bio


Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.

MMSI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$57.91$31.49 -46%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Merit Medical Systems Inc. To summarize, we found that Merit Medical Systems Inc ranked in the 37th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MMSI, they are:

  • Merit Medical Systems Inc's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 71.21% of tickers in our DCF set.
  • Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.08. This coverage rate is greater than that of just 17.39% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • As a business, Merit Medical Systems Inc experienced a tax rate of about 18% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 77.68% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-47%
1%-46%
2%-46%
3%-45%
4%-44%
5%-44%

CRL, PKI, IART, MGLN, and ITGR can be thought of as valuation peers to MMSI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


MMSI Latest News Stream


Event/Time News Detail
Loading, please wait...

MMSI Latest Social Stream


Loading social stream, please wait...

View Full MMSI Social Stream

Latest MMSI News From Around the Web

Below are the latest news stories about Merit Medical Systems Inc that investors may wish to consider to help them evaluate MMSI as an investment opportunity.

Interventional Cardiovascular Device Market to Witness Huge Growth by 2021-2027| Key Players are GE Healthcarem, Boston Scientific, Philips, Volcano Therapeutics, Argon Medical, Spectranetics, Angio Dynamics, AccessClosure, Merit Medical Systems, B. Braun

ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Interventional Cardiovascular Device Market Research Report 2021”. The Global Interventional Cardiovascular Device Market Report 2021 is a professional and in-depth study on the current state of the

OpenPR | January 12, 2021

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

Integer Holdings (ITGR) continues to gain traction from portfolio management. However, intense competition is a woe.

Yahoo | January 5, 2021

Merit Medical Systems (MMSI) Sees Hammer Chart Pattern: Time to Buy?

Merit Medical Systems (MMSI) has been struggling lately, but the selling pressure may be coming to an end soon.

Yahoo | January 5, 2021

Nevro's (NVRO) FDA Submission to Treat Patients With PDN

Nevro's (NVRO) submission of a pre-market approval supplement to the FDA to seek approval for its Senza System can help in the treatment of chronic pain associated with PDN.

Yahoo | December 29, 2020

Global Angioplasty Balloons Market (2020 to 2025) - Increasing Preference for Minimally Invasive Procedures is Driving Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Angioplasty Balloons Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The rise in the geriatric population could result in an exponential increase in Coronary heart disease prevalence, which, in turn, is propelling the angioplasty balloons market. Companies Mentioned Abbot Laboratories AngioDynamics BIOTRONIK Boston Scientific Corporation Cook Medical Cordis (Cardinal Health) Medtronic Merit Medical S

Business Wire | December 28, 2020

Read More 'MMSI' Stories Here

MMSI Price Returns

1-mo N/A
3-mo 18.09%
6-mo 24.03%
1-year 58.31%
3-year 23.21%
5-year 260.14%
YTD 4.32%
2020 77.80%
2019 -44.06%
2018 29.19%
2017 63.02%
2016 42.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0355 seconds.